Have you been diagnosed with absense seizures?
Consider joining this new clinical study
The T-WAVE clinical study will evaluate whether an investigational oral drug for adolescents and adults diagnosed with absence seizures is safe and investigate how the drug works. Researchers will also explore if the drug is effective in decreasing the frequency and duration of seizures by reducing abnormal activity in certain regions of the brain.
You or a loved one may be eligible for this study if you:
- Are 16-55 years old and not pregnant or breastfeeding
- Have been diagnosed with an idiopathic generalized epilepsy (IGE) such as childhood absence epilepsy, juvenile absence epilepsy, juvenile myoclonic epilepsy, or Jeavons syndrome with absence seizures
- Are on a stable dose of anti-epileptic medication for at least 30 days, or have documentation justifying lack of therapy
- Have no history of surgical intervention for the treatment of epilepsy